Literature DB >> 12030846

Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase.

Andrea Murányi1, Justin A MacDonald, Jing Ti Deng, David P Wilson, Timothy A J Haystead, Michael P Walsh, Ferenc Erdodi, Eniko Kiss, Yue Wu, David J Hartshorne.   

Abstract

A mechanism proposed for regulation of myosin phosphatase (MP) activity is phosphorylation of the myosin phosphatase target subunit (MYPT1). Integrin-linked kinase (ILK) is associated with the contractile machinery and can phosphorylate myosin at the myosin light-chain kinase sites. The possibility that ILK may also phosphorylate and regulate MP was investigated. ILK was associated with the MP holoenzyme, shown by Western blots and in-gel kinase assays. MYPT1 was phosphorylated by ILK and phosphorylation sites in the N- and C-terminal fragments of MYPT1 were detected. From sequence analyses, three sites were identified: a primary site at Thr(709), and two other sites at Thr(695) and Thr(495). One of the sites for cAMP-dependent protein kinase (PKA) was Ser(694). Assays with the catalytic subunit of type 1 phosphatase indicated that only the C-terminal fragment of MYPT1 phosphorylated by zipper-interacting protein kinase, and ILK inhibited activity. The phosphorylated N-terminal fragment activated phosphatase activity and phosphorylation by PKA was without effect. Using full-length MYPT1 constructs phosphorylated by various kinases it was shown that Rho kinase gave marked inhibition; ILK produced an intermediate level of inhibition, which was considerably reduced for the Thr(695)-->Ala mutant; and PKA had no effect. In summary, phosphorylation of the various sites indicated that Thr(695) was the major inhibitory site, Thr(709) had only a slight inhibitory effect and Ser(694) had no effect. The findings that ILK phosphorylated both MYPT1 and myosin and the association of ILK with MP suggest that ILK may influence cytoskeletal structure or function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030846      PMCID: PMC1222775          DOI: 10.1042/BJ20020401

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis.

Authors:  Y Wang; W Guo; L Liang; W J Esselman
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

2.  Interaction of smooth muscle myosin phosphatase with phospholipids.

Authors:  M Ito; J Feng; S Tsujino; N Inagaki; M Inagaki; J Tanaka; K Ichikawa; D J Hartshorne; T Nakano
Journal:  Biochemistry       Date:  1997-06-17       Impact factor: 3.162

3.  Interactions of the subunits of smooth muscle myosin phosphatase.

Authors:  K Hirano; B C Phan; D J Hartshorne
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Myosin binding subunit of smooth muscle myosin phosphatase at the cell-cell adhesion sites in MDCK cells.

Authors:  N Inagaki; M Nishizawa; M Ito; M Fujioka; T Nakano; S Tsujino; K Matsuzawa; K Kimura; K Kaibuchi; M Inagaki
Journal:  Biochem Biophys Res Commun       Date:  1997-01-23       Impact factor: 3.575

5.  Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1.

Authors:  D L Morrison; J S Sanghera; J Stewart; C Sutherland; M P Walsh; S L Pelech
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

6.  Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity.

Authors:  K Ichikawa; M Ito; D J Hartshorne
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

Review 7.  Myosin light chain phosphatase: subunit composition, interactions and regulation.

Authors:  D J Hartshorne; M Ito; F Erdödi
Journal:  J Muscle Res Cell Motil       Date:  1998-05       Impact factor: 2.698

8.  Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.

Authors:  S Endo; X Zhou; J Connor; B Wang; S Shenolikar
Journal:  Biochemistry       Date:  1996-04-23       Impact factor: 3.162

9.  Differential localization of myosin and myosin phosphatase subunits in smooth muscle cells and migrating fibroblasts.

Authors:  K Murata; K Hirano; E Villa-Moruzzi; D J Hartshorne; D L Brautigan
Journal:  Mol Biol Cell       Date:  1997-04       Impact factor: 4.138

10.  Regulation of cell motility by mitogen-activated protein kinase.

Authors:  R L Klemke; S Cai; A L Giannini; P J Gallagher; P de Lanerolle; D A Cheresh
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

View more
  58 in total

1.  Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Satoshi Matsuo; Katsuharu Kameda; Mayumi Hirano; Akira Nakamizo; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-28       Impact factor: 6.200

2.  Localization of myosin phosphatase target subunit and its mutants.

Authors:  Yue Wu; Andrea Murányi; Ferenc Erdodi; David J Hartshorne
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

3.  Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries.

Authors:  Ahmed F El-Yazbi; Rosalyn P Johnson; Emma J Walsh; Kosuke Takeya; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

4.  Integrin-linked kinase is responsible for Ca2+-independent myosin diphosphorylation and contraction of vascular smooth muscle.

Authors:  David P Wilson; Cindy Sutherland; Meredith A Borman; Jing Ti Deng; Justin A Macdonald; Michael P Walsh
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.

Authors:  Lori D Moffat; Shannon B A Brown; Michael E Grassie; Annegret Ulke-Lemée; Laura M Williamson; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

6.  Remanent cell traction force in renal vascular smooth muscle cells induced by integrin-mediated mechanotransduction.

Authors:  Lavanya Balasubramanian; Chun-Min Lo; James S K Sham; Kay-Pong Yip
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

Review 7.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Rho-regulated myosin phosphatase establishes the level of protrusive activity required for cell movements during zebrafish gastrulation.

Authors:  Douglas C Weiser; Richard H Row; David Kimelman
Journal:  Development       Date:  2009-06-10       Impact factor: 6.868

9.  Par-4: a new activator of myosin phosphatase.

Authors:  Susanne Vetterkind; Eunhee Lee; Eric Sundberg; Ransom H Poythress; Terence C Tao; Ute Preuss; Kathleen G Morgan
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

10.  Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats.

Authors:  Paola Failli; Chiara Alfarano; Sergio Franchi-Micheli; Edoardo Mannucci; Elisabetta Cerbai; Alessandro Mugelli; Laura Raimondi
Journal:  Cardiovasc Diabetol       Date:  2009-06-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.